The Michael J. Fox Foundation (MJFF) engages companies to enhance our programs through funding, in-kind contributions, strategic input and more. Below are key MJFF initiatives and the programmatic partners that help make them possible.
The Parkinson's Progression Markers Initiative (PPMI) an MJFF-sponsored landmark clinical study to identify biomarkers of Parkinson's disease. PPMI is sponsored by MJFF and is funded by MJFF and a consortium of key industry players, non-profit organizations and private individuals. Industry partners are contributing to PPMI through financial and in-kind donations and are playing a lead role in providing feedback on study design through the Industry Scientific Advisory Board.
MJFF is eager to partner with industry organizations to continue PPMI's success. Contact us at firstname.lastname@example.org.
The Michael J. Fox Foundation and AbbVie have partnered to create Partners in Parkinson's, a strategic health initiative providing educational tools and resources to help people with Parkinson's disease optimize their care from diagnosis through advanced disease. Visit partnersinparkinsons.org to learn more
The Michael J. Fox Foundation and Intel have partnered to launch an initiative harnessing the power of big data to measure Parkinson's disease symptoms and progression. Through the development of applications for wearable devices, including smartphones and smartwatches, and analytics platforms, researchers will be able to access this data in their work to speed progress towards breakthroughs in drug development.
To develop and characterize research tools that meet the greatest needs of the field, the Foundation launched the Parkinson's Disease Research Tools Consortium. In this precompetitive consortium, MJFF and industry partners work to better understand existing tools and their use in laboratory experiments, as well as to develop new tools to address current challenges.
Industry groups interested in joining the consortium are invited to contact us at email@example.com